DarioHealth Statistics
Total Valuation
DarioHealth has a market cap or net worth of $20.47 million. The enterprise value is $30.14 million.
Important Dates
The last earnings date was Tuesday, August 12, 2025, before market open.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
DarioHealth has 45.50 million shares outstanding. The number of shares has increased by 63.26% in one year.
| Current Share Class | 45.50M |
| Shares Outstanding | 45.50M |
| Shares Change (YoY) | +63.26% |
| Shares Change (QoQ) | +4.77% |
| Owned by Insiders (%) | 12.76% |
| Owned by Institutions (%) | 20.83% |
| Float | 39.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.90 |
| Forward PS | 0.51 |
| PB Ratio | 0.32 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.11 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.30, with a Debt / Equity ratio of 0.49.
| Current Ratio | 3.30 |
| Quick Ratio | 2.77 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -66.92% and return on invested capital (ROIC) is -26.75%.
| Return on Equity (ROE) | -66.92% |
| Return on Assets (ROA) | -22.55% |
| Return on Invested Capital (ROIC) | -26.75% |
| Return on Capital Employed (ROCE) | -42.18% |
| Revenue Per Employee | $134,396 |
| Profits Per Employee | -$176,811 |
| Employee Count | 202 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 1.70 |
Taxes
In the past 12 months, DarioHealth has paid $164,000 in taxes.
| Income Tax | 164,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.78% in the last 52 weeks. The beta is 1.24, so DarioHealth's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | -50.78% |
| 50-Day Moving Average | 0.65 |
| 200-Day Moving Average | 0.71 |
| Relative Strength Index (RSI) | 25.38 |
| Average Volume (20 Days) | 197,110 |
Short Selling Information
The latest short interest is 3.04 million, so 6.68% of the outstanding shares have been sold short.
| Short Interest | 3.04M |
| Short Previous Month | 2.96M |
| Short % of Shares Out | 6.68% |
| Short % of Float | 7.70% |
| Short Ratio (days to cover) | 18.78 |
Income Statement
In the last 12 months, DarioHealth had revenue of $27.15 million and -$35.72 million in losses. Loss per share was -$0.66.
| Revenue | 27.15M |
| Gross Profit | 18.87M |
| Operating Income | -41.58M |
| Pretax Income | -52.73M |
| Net Income | -35.72M |
| EBITDA | -35.26M |
| EBIT | -41.58M |
| Loss Per Share | -$0.66 |
Full Income StatementBalance Sheet
The company has $21.95 million in cash and $31.62 million in debt, giving a net cash position of -$9.67 million or -$0.21 per share.
| Cash & Cash Equivalents | 21.95M |
| Total Debt | 31.62M |
| Net Cash | -9.67M |
| Net Cash Per Share | -$0.21 |
| Equity (Book Value) | 63.99M |
| Book Value Per Share | 1.41 |
| Working Capital | 22.42M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$26.79 million and capital expenditures -$128,000, giving a free cash flow of -$26.92 million.
| Operating Cash Flow | -26.79M |
| Capital Expenditures | -128,000 |
| Free Cash Flow | -26.92M |
| FCF Per Share | -$0.59 |
Full Cash Flow StatementMargins
Gross margin is 69.49%, with operating and profit margins of -153.15% and -162.73%.
| Gross Margin | 69.49% |
| Operating Margin | -153.15% |
| Pretax Margin | -162.13% |
| Profit Margin | -162.73% |
| EBITDA Margin | -129.87% |
| EBIT Margin | -153.15% |
| FCF Margin | n/a |
Dividends & Yields
DarioHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -63.26% |
| Shareholder Yield | -63.26% |
| Earnings Yield | -174.45% |
| FCF Yield | -131.49% |
Analyst Forecast
The average price target for DarioHealth is $2.50, which is 455.68% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.50 |
| Price Target Difference | 455.68% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 19.53% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 18, 2019. It was a reverse split with a ratio of 1:20.
| Last Split Date | Nov 18, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
DarioHealth has an Altman Z-Score of -5.84 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.84 |
| Piotroski F-Score | 4 |